Bijan Shahbazkhani

Bijan Shahbazkhani


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2015 in Nutrients
Verified
Journal Article
Open access
PDF file
BSBijan Shahbazkhani
Bijan Shahbazkhani
ASAmirsaeid Sadeghi
Amirsaeid Sadeghi
RMReza Malekzadeh
Reza Malekzadeh
FKFatima Khatavi
Fatima Khatavi
MEMehrnoosh Etemadi
Mehrnoosh Etemadi
Kamran RostamiKamran Rostami
Kamran Rostami
Several studies have shown that a large number of patients who are fulfilling the criteria for irritable bowel syndrome (IBS) are sensitive to gluten. The aim of this study was to evaluate the effect of a gluten-free diet on gastrointestinal symptoms in patients with IBS. In this double-blind randomized, placebo-controlled trial, 148 IBS patients fulfilling the Rome III criteria were enrolled between 2011 and 2013. However, only 72 out of the 148 commenced on a gluten-free diet for up to six weeks and completed the study; clinical symptoms were recorded biweekly using a standard visual analogue scale (VAS). In the second stage after six weeks, patients whose symptoms improved to an acceptable level were randomly divided into two groups; patients either received packages containing powdered gluten (35 cases) or patients received placebo (gluten free powder) (37 cases). Overall, the symptomatic improvement was statistically different in the gluten-containing group compared with placebo group in 9 (25.7%), and 31 (83.8%) patients respectively (p < 0.001). A large number of patients labelled as irritable bowel syndrome are sensitive to gluten. Using the term of IBS can therefore be misleading and may deviate and postpone the application of an effective and well-targeted treatment strategy in gluten sensitive patients.

27 April 2021 in Rheumatology
Verified
Journal Article
Open access
ZSZahra Soltani
Zahra Soltani
ABAzarakhsh Baghdadi
Azarakhsh Baghdadi
MNMohammad Nejadhosseinian
Mohammad Nejadhosseinian
SFSeyedeh Tahereh Faezi
Seyedeh Tahereh Faezi
BSBijan Shahbazkhani
Bijan Shahbazkhani
KKKiarash Kazemi
Kiarash Kazemi
Introduction: Celiac disease (CD) is one of the most common chronic diseases. Celiac disease has been associated with several autoimmune disorders, but the association with systemic lupus erythematosus (SLE) as a systemic autoimmune disease is still controversial. In this study, we aimed to determine the prevalence of biopsy-proven CD in patients with SLE, and to determine the clinical symptoms and laboratory data in these patients.Material and methods: In a cross-sectional study, SLE patients at a referral clinic were evaluated for gastrointestinal symptoms between March and December 2016. Patients were evaluated by a gastroenterologist, and upper gastrointestinal endoscopy with intestinal biopsy was performed if deemed necessary. The clinical symptoms, laboratory data, and endoscopy results were recorded and compared between groups.Results: In total, 130 patients were evaluated in this study. Gastrointestinal symptoms were present in 40% of the patients. Endoscopy was performed in all SLE patients with gastrointestinal symptoms. Four patients (3%) were diagnosed as having CD based on biopsy results and response to a gluten-free diet. Anti-endomysium antibody (AEA) was found to be 100% sensitive and 99.2% specific for the diagnosis of CD in SLE patients, and anti-gliadin antibody (AGA) had a 50% sensitivity and 98% specificity. Patients with comorbid CD and SLE were significantly more likely to have diarrhea, abdominal pain, nausea/vomiting, recurrent oral aphthosis, and anemia.Conclusions: The results of this study suggest that a significant association is present between CD and SLE. We found a prevalence of 3% for biopsy-proven CD in patients with SLE, which is five times the prevalence of CD in the general population.

Verified
Open access
MMMasoume Mansouri
Masoume Mansouri
MDMasoud Dadfar
Masoud Dadfar
MRMohammad Rostami-Nejad
Mohammad Rostami-Nejad
GEGolnaz Ekhlasi
Golnaz Ekhlasi
ASAmirhossein Shahbazkhani
Amirhossein Shahbazkhani
BSBijan Shahbazkhani
Bijan Shahbazkhani
We evaluated the frequency of human leukocyte antigen (HLA) DQ2/DQ8 haplotypes as well as celiac disease (CD) among the first-degree relatives (FDRs) of CD patients, compared with healthy controls, and compared the HLA typing with serologic tests in this population. Until now, no study has examined the frequency of HLA-DQ2/DQ8 haplotypes among the FDRs of Iranian patients with CD. In the current case-control study, 100 FDRs of CD patients and 151 healthy controls were included. Demographic characteristics were assessed using a research-made questionnaire. A blood sample was collected from each participant for HLA-DQ typing and measuring serum levels of anti-gliadin and anti-transglutaminase (anti-tTG) antibodies. The mean age of the FDRs of CD patients and controls was 30 and 35 years, respectively. Also, 51% (n=51) of the FDRs and 51.7% (n=78) of controls were female. CD was diagnosed among 3% (n=3) of the FDRs of CD patients. No significant difference was found in terms of the frequency of HLA-DQ alleles between the FDRs of CD patients and controls. Out of 100 FDRs of CD patients, 40% had HLA-DQ2 allele, 16% carried HLA-DQ8 allele, and 4% had both alleles. Surprisingly, the CD was diagnosed in three subjects among 60 FDRs of CD patients with HLA-DQ2 allele (3% of the whole population). This diagnosis was based on the results of serological tests as well as endoscopy and intestinal biopsy. CD was confirmed among 3% (n=3) of the FDRs of CD patients. We found that HLA typing is not effective in predicting CD among FDRs of CD patients. Other methods such as serological tests have a higher priority compared with HLA-DQ typing.


13 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ZTZohreh Tajabadi
Zohreh Tajabadi
GEGolnaz Ekhlasi
Golnaz Ekhlasi
MDMaryam Daneshpazhooh
Maryam Daneshpazhooh
HFHafez Fakheri
Hafez Fakheri
TTTahmine Tavakoli
Tahmine Tavakoli
BSBijan Shahbazkhani
Bijan Shahbazkhani
Background: While celiac disease (CD) ordinarily presents with gastrointestinal manifestations, extraintestinal appearances may also happen. Although cutaneous manifestations are one of the most common extraintestinal manifestations of CD, little is known about their prevalence and associated factors. This study aims to determine the prevalence of cutaneous manifestations and related factors in CD patients. Methods: This cross-sectional study enrolled CD patients referred to the National Celiac Registry, for whom a diagnosis of CD was confirmed through clinical examination, serological testing, and intestinal biopsy. Data on demographic characteristics, CD staging, clinical manifestations, underlying comorbidities, and family history (FH) of diseases were collected. Data were analyzed using SPSS version 25.0. A p -value less than 0.05 was considered significant. Results: Of the 4357 enrolled CD patients (male 65.7%), 18.20% had cutaneous manifestations, with eczema (3.73%), dermatitis herpetiformis (3.46%), and psoriasis (0.71%) being the most common disorders. The FH of skin disorders (Odds ratio (OR)=7.99, 95% confidence interval (CI) 2.44-26.13, p =0.00), osteoarthritis (OR=6.15, 95% CI 1.15-32.78, p =0.03), Sjögren syndrome (OR=4.82, 95% CI 1.98-11.73, p =0.00), mouth aphthae (OR=3.10, 95% CI 1.80-5.32, p =0.00), thalassemia (OR=2.78, 95% CI 1.19-6.50, p =0.01), constipation (OR =1.62, 95% CI 1.10-2.38, p =0.01), and iron deficiency anemia (IDA) (OR=1.54, 95% CI 1.05-2.24, p =0.02) were independent predictors, and type I diabetes mellitus (OR=0.20, 95% CI 0.05-0.81, p =0.02) was a protective factor for skin diseases. Conclusion: Considering the higher probability of cutaneous manifestations in CD patients, regular clinical evaluation of these patients is recommended for timely diagnosis and management of underlying skin diseases.